Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study
Frontiers in Oncology · 13.07.2026 · 16
DOI: 10.3389/fonc.2026.1826692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 13.07.2026. Verfasst von Zhongyan Dou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospi…. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to identify prognostic factors and establish a nomogram for predicting overall survival (OS) in hepatitis B surface antigen-positive (HBsAg-positive) cervical cancer (CC) patients.
Methods
A retrospective analysis of 149 HBsAg-positive CC patients treated at Yunnan Cancer Hospital (2015–2017) was performed. Cox regression identified independent prognostic factors for nomogram development. The nomogram’s predictive accuracy and discriminative capability were evaluated through Harrell’s concordance index (C-index), calibration plots, and decision curve analysis, and its performance was compared to the International Federation of Gynecology and Obstetrics (FIGO) staging system. Internal validation was conducted using the bootstrap resampling method.
Results
Multivariate Cox regression analyses identified tumor stage, baseline serum AST levels, antiviral therapy, lymph node status, and treatment modality as independent prognostic factors for patients with HBsAg-positive CC, all of which were incorporated into the nomogram for OS. The Harrell’s C-index of nomogram was 0.817 (95% confidence interval [CI], 0.762–0.873), which was higher than that of FIGO staging system 0.700 (95% CI, 0.637–0.764, P < 0.001). Moreover, the nomogram showed superior performance in decision curve analysis (DCA) and a higher area under the curve (AUC) compared to the FIGO staging system. The calibration curve for survival probability exhibited good consistency between the probabilities and observed values. Grouping based on the nomogram’s cutoff value showed that the high-risk group experienced significantly poorer OS than the low-risk group ( P < 0.001).
Conclusions
This study established a nomogram for the preliminary prognostic evaluation of OS in HBsAg-positive CC patients. Further validation is required prior to its clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, China.
- Department of Medical Administration, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, China.
Zitieren
APA
Dou, Z., Yu, S., Zhang, J., Wu, X., Li, K., Jiang, M., Zhao, C., & Zhang, L. (2026). Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1826692
Vancouver
Dou Z, Yu S, Zhang J, Wu X, Li K, Jiang M, et al. Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1826692
BibTeX
@article{Dou2026,
author = {Dou, Zhongyan and Yu, Shuhui and Zhang, Jinping and Wu, Xingrao and Li, Kangming and Jiang, Meiping and Zhao, Chunfang and Zhang, Lan},
title = {Establishment of prognostic nomogram in cervical cancer with hepatitis B virus infection: a retrospective study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1826692}
}
EUVIMED